Incidence of Kidney Disease

Benzinga  Jun 23  Comment 
Cara Therapeutics Inc (NASDAQ: CARA) shares are trading higher by $2.50 (12 percent) at $22.38 in Friday's session. The catalyst for the rally is the announcement that the IV CR845 has received Breakthrough Therapy designation for the treatment...
The Hindu Business Line  Jun 15  Comment 
Shares of Aurobindo Pharma today surged almost 7 per cent as the company received USFDA nod to make oral suspension used for controlling serum phosphorus in patients with chronic kidney disease on di...
The Economic Times  Jun 15  Comment 
Sevelamer Carbonate oral suspension is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
FiercePharma  Jun 12  Comment 
Eli Lilly and Boehringer Ingelheim have reason to believe their SGLT2 inhibitor, Jardiance, may be able to improve outcomes for chronic kidney disease patients—so they’re putting the med to the test.
Motley Fool  May 16  Comment 
Akebia Therapeutics gets a sizable equity investment from Vifor Pharma as part of a supply agreement for the experimental anemia drug vadadustat.
MedPage Today  Apr 26  Comment 
(MedPage Today) -- Sub-analysis in patients with chronic kidney disease and T2DM raised no safety concerns
MedPage Today  Apr 20  Comment 
(MedPage Today) -- Experts say technology basis for patient care and prevention
Motley Fool  Mar 28  Comment 
Cara Therapeutics has reported positive mid-stage trial results for its lead drug candidate, clearing the way for a late-stage trial to begin soon.
DailyFinance  Mar 17  Comment 
Filed under: Lifestyle, Living, Pets A Virginia animal shelter has put out a desperate plea with the hope that a sick dog will go to a loving home before he dies of kidney failure. Read more...   Permalink | Email...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki